| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |